← Evidence map

ArticleMolecular cancer therapeutics2017

Cotargeting mTORC and EGFR Signaling as a Therapeutic Strategy in HNSCC.

Adam D Swick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

29 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 28446642